tiprankstipranks
Apogee Therapeutics (APGE)
NASDAQ:APGE
US Market

Apogee Therapeutics (APGE) Income Statement

Compare
169 Followers

Apogee Therapeutics Income Statement

Last quarter (Q3 2024), Apogee Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Apogee Therapeutics's net income was $-49.02M. See Apogee Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 93.00M$ 30.73M
Depreciation and Amortization
$ 9.02M$ 33.52M
EBITDA
$ -83.98M$ 0.00
Operating Income
$ -93.00M$ -30.73M
Other Income/Expenses
$ 9.02M$ -9.06M
Pretax Income
$ -83.98M$ -39.78M
Net Income
$ -83.98M$ -39.78M
Per Share Metrics
$ ―$ ―
Basic EPS
$ -3.36$ -0.79
Diluted EPS
$ -3.36$ -0.79
Weighted Average Shares Outstanding
25.00M 50.67M
Weighted Average Shares Outstanding (Diluted)
25.00M 50.67M
Currency in USD

Apogee Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis